# Venus Medtech completes acquisition of 100% of Cardiovalve

Venus Medtech (Hangzhou) Inc. concluded its acquisition of 100% equity interest in Cardiovalve Ltd., an Israeli transcatheter mitral and tricuspid valve treatment company, on January 26, 2022.

- Type: Acquisition
- Announced: 2022-01-26
- Status: completed
- Products: transcatheter mitral valve replacement system, transcatheter tricuspid valve replacement system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cardiovalve](https://endata.com/companies/59531.md) (target)
- [Venus Medtech (Hangzhou) Inc.](https://endata.com/companies/60598.md) (acquirer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/venus-medtech-concludes-acquisition-of-100-equity-interest-in-cardiovalve-301468315.html), 2022-01-26: "Venus Medtech (Hangzhou) Inc. announced its acquisition of 100% equity interest in Cardiovalve Ltd. was concluded on 26th January, 2022."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.